TMBS E423: Ray and Jo-Anne Page – Talk about new hope for bladder cancer sufferers with INLEXZO

Johnson and Johnson is offering new hope for bladder cancer sufferers with INLEXZO. Mark talks with Ray and JoAnne Page husband and wife (nurse and patient), about what this drug has been able to do for a severe cancer case. Get The Facts on The Mark Bishop Show.

Start listening

Johnson and Johnson is offering new hope for bladder cancer sufferers with INLEXZO. Mark talks with Ray and JoAnne Page husband and wife (nurse and patient), about what this drug has been able to do for a severe cancer case. Get The Facts on The Mark Bishop Show.

BIOs ~ RAY AND JOANNE PAGE 

Ray is a retired carpenter, construction worker, and former theater owner who was diagnosed with non-muscle invasive bladder cancer (NMIBC) in 2025 after visiting his urologist for frequent urination.

After surgery and becoming unresponsive to BCG treatment, Ray faced the possibility of bladder removal. With guidance from his care team, Ray began treatment with INLEXZO® (gemcitabine intravesical system) in January 2026.  
 
Since starting treatment, he has shown no evidence of disease. Ray now shares his experience with other patients through advocacy organizations like the Bladder Cancer Advocacy Network (BCAN) and patient forums to help people understand their options, show how a committed care partner can help them speak up, explore new treatment possibilities and feel more supported throughout their care journey. 

JoAnne is Ray’s wife and care partner, bringing a unique perspective to his bladder cancer journey as his spouse and a nurse who previously worked in oncology. JoAnne has supported Ray through challenges with BCG treatment, the uncertainty of recurrence, and the possibility of bladder removal, while helping him navigate treatment options. Bladder cancer is among the top 10 most commonly diagnosed cancers in the United States, according to the Bladder Cancer Advocacy Network (BCAN).1